Zobrazeno 1 - 10
of 97
pro vyhledávání: ''
Publikováno v:
European Radiology; Dec2019, Vol. 29 Issue 12, p7000-7008, 9p, 3 Diagrams, 5 Charts
Autor:
Zsuzsanna Varga, Thomas Ruhstaller, Ulrike Perriard, Dirk Klingbiel, Tilman T. Rau, Jean-Christophe Tille, Beat Thuerlimann, Hanne Hawle, Qiyu Li, Wolfram Jochum
Publikováno v:
Varga, Zsuzsanna; Li, Qiyu; Jochum, Wolfram; Perriard, Ulrike; Rau, Tilman; Tille, Jean-Christoph; Hawle, Hanne; Klingbiel, Dirk; Thuerlimann, Beat; Ruhstaller, Thomas (2019). Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort. Scientific reports, 9(1), p. 13534. Springer Nature 10.1038/s41598-019-49638-4
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, Vol. 9, No 1 (2019) P. 13534
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-11 (2019)
Scientific Reports, Vol. 9, No 1 (2019) P. 13534
Scientific Reports
The assessment of Ki-67 in early-stage breast cancer has become an important diagnostic tool in planning adjuvant therapy, particularly for the administration of additional chemotherapy to hormone-responsive patients. An accurate determination of the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::509ed0eb6c511bb431eb561f8c240921
Autor:
Arja Jukkola-Vuorinen, Anniina Jääskeläinen, Kirsi-Maria Haapasaari, Päivi Auvinen, Ylermi Soini, Peeter Karihtala
Publikováno v:
BMC Cancer
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Background: The subtype of claudin-low breast cancer can be reliably determined only by gene-expression profiling. Attempts have been made to develop immunohistochemical surrogates, which nearly always focus on membranous claudin expression. Methods:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0882fc6ea4b5d717997d116945eea4b4
http://urn.fi/urn:nbn:fi-fe201804196713
http://urn.fi/urn:nbn:fi-fe201804196713
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background The human Y-box-binding protein 1 (YB-1) is a member of the DNA/RNA-binding family of proteins that regulates transcription and translation of genes. Previous studies suggest that YB-1 may have an oncogenic role in various cancers. In this
Autor:
Marian B. E. Menke-Pluymers, Paul I.M. Schmitz, Carmen C. van der Pol, Titia E. Lans, Albertus N. van Geel
Publikováno v:
Annals of Surgical Oncology
Background Full-thickness chest wall resection (CWR) is the preferred treatment for breast cancer (BC) patients with extensive isolated locoregional recurrence. It remains a challenge to select patients that will benefit most from this treatment. The
Fresh Surgical Specimens Yield Breast Stem/Progenitor Cells and Reveal Their Oncogenic Abnormalities
Autor:
Ariel L. Hernandez, Jennifer A. Murphy, Rodney F. Pommier, Juliana E. Hansen, Patrick Muller, Arpana Naik, Esther Han, John T. Vetto, Brian S. Diggs, Su Ellen J. Pommier, Kristen P. Massimino, Erin Chamberlain
Publikováno v:
Annals of Surgical Oncology
Background The process by which breast cancer stem cells arise is unknown. It may be that the benign stem cells in breast tissue are transformed into malignant stem cells through the acquisition of genetic abnormalities. In this study, we collected a
Autor:
Heerma van Voss, Marise R., Schrijver, Willemijne A M E, Ter Hoeve, Natalie D., Hoefnagel, Laurien D., Manson, Quirine F., van der Wall, Elsken, Raman, Venu, van Diest, Paul J., Dutch Distant Breast Cancer Metastases Consortium, Distant Breast Cancer Metastases Consortium
Publikováno v:
Clinical & Experimental Metastasis, 34(1), 85–92. Springer Netherlands
Clinical & Experimental Metastasis, 34(1), 85-92. SPRINGER
Clinical & Experimental Metastasis
Clinical & Experimental Metastasis, 34(1), 85-92. SPRINGER
Clinical & Experimental Metastasis
Metastatic breast cancer remains one of the leading causes of death in women and identification of novel treatment targets is therefore warranted. Functional studies showed that the RNA helicase DDX3 promotes metastasis, but DDX3 expression was never
Autor:
Dimitrios H Roukos, Dimosthenis Ziogas
Publikováno v:
Annals of Surgical Oncology. 16(10):2678-2681
Gastric cancer has a poor prognosis. Primary prevention is a major goal to reduce incidence and mortality, but it is still an illusion. There is an exception: the rare hereditary diffuse gastric cancer (HDGC). This syndrome can be both accurately pre
Autor:
Masayuki Yoshida, Kenichi Sugihara, Takashi Hojo, Hitoshi Tsuda, Nobuko Tamura, Sadako Akashi-Tanaka, Takayuki Kinoshita
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Ipsilateral breast tumor recurrence (IBTR) after partial breast resection and contralateral breast tumor recurrence (CBTR) have been shown to occur relatively frequently in patients with ductal carcinoma in situ (DCIS). However, there is o
Autor:
Katsumasa Kuroi, Seigo Nakamura, Nobuaki Sato, Hiroji Iwata, Masakazu Toi, Futoshi Akiyama, Masafumi Kurosumi, Norikazu Masuda, Hitoshi Tsuda, Shinji Ohno
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Neoadjuvant chemotherapy (NAC) has been accepted as one of the standard treatments for operable breast cancer. However, the term pathologic complete response (pCR) has not been consistently defined. Methods This study was a pooled analysis